Enhanced filter paper enzyme assay for high-throughput population screening for Fabry disease

Analytical Biochemistry

Volumn 337, Issue 1, 2005, Pages 161-163

  Poeppl, Armando G ^a   Murray, Gary J ^d   Medin, Jeffrey A ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMISTRY;

ENZYME ASSAYS; FABRY DISEASE; FILTER PAPERS; HIGH THROUGHPUT;

DIAGNOSIS;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME ASSAY; FABRY DISEASE; FILTER; HUMAN; MASS SCREENING; PRIORITY JOURNAL;

EID: 11844304402     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.10.007     Document Type: Article

References (10)

1. R.J. Desnick, Y.A. Ioannou, C.M. Eng, The Metabolic Bases of Inherited Disease, 7th ed. vol. 2, McGraw-Hill, New York, 1995, pp. 2741-2784
2. S. Nakao, T. Takenaka, M. Maeda, C. Kodama, A. Tanaka, M. Tahara, A. Yoshida, M. Kuriyama, H. Hayashibe, H. Sakuraba, and H. Tanaka An atypical variant of Fabry's disease in men with left ventricular hypertrophy N. Engl. J. Med. 333 1995 288 293
3. S. Nakao, C. Kodama, T. Takenaka, A. Tanaka, Y. Yasumoto, A. Yoshida, T. Kanzaki, A.L.D. Enriquez, C.M. Eng, H. Tanaka, S. Tei, and R.J. Desnick Fabry disease: detection of undiagnosed hemodialysis patients and identification of a renal variant phenotype Kidney Int. 64 2003 801 807
4. R. Schiffmann, J.B. Kopp, H.A. Austin, S. Sabnis, D.F. Moore, T. Weibel, J.E. Balow, and R.O. Brady Enzyme replacement therapy in Fabry disease J. Am. Med. Assoc. 285 2001 2743 2749
5. C.M. Eng, N. Guffon, W.R. Wilcox, D.P. Germain, P. Lee, S. Waldek, L. Caplan, G.E. Linthorst, R.J. Desnick, International Collaborative Fabry Disease Study Group. Safety and efficacy of recombinant human {α}-galactosidase A replacement therapy in [6] Fabry's disease. N. Engl. J. Med. 2001 345 (2001) 9-16
6. C. Siatskas, and J.A. Medin Gene therapy for Fabry disease J. Inherit. Metab. Dis. 24 2001 25 41
7. G. Qin, T. Takenaka, K. Telsch, L. Kelley, T. Howard, T. Levade, R. Deans, B.H. Howard, H.L. Malech, R.O. Brady, and J.A. Medin Preselective gene therapy for Fabry disease Proc. Natl. Acad. Sci. USA 98 2001 3428 3433
8. T. Takenaka, G.J. Murray, G. Qin, J.M. Quirk, T. Ohshima, P. Qasba, K. Clark, A.B. Kulkarni, R.O. Brady, and J.A. Medin Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells Proc. Natl. Acad. Sci. USA 97 2000 7515 7520
9. N.A. Chamoles, M. Blanco, and D. Gaggiolo Fabry disease: enzymatic diagnosis in dried blood spots on filter paper Clin. Chim. Acta 308 2001 195 196
10. T. Ohshima, R. Schiffmann, G.J. Murray, J. Kopp, J.M. Quirk, S. Stahl, C.C. Chan, P. Zerfas, J.H. Tao-Cheng, J.M. Ward, R.O. Brady, and A.B. Kulkarni Aging accentuates and bone marrow transplantantion ameliorates metabolic defects in Fabry disease mice Proc. Natl. Acad. Sci. USA 96 1999 6423 6427